Bortezomib-Induced Myocarditis in a Patient With Multiple Myeloma

Key Result

Early recognition, stopping bortezomib, and timely heart failure treatment enable full recovery from bortezomib-induced myocarditis in multiple myeloma patients.

Key Points

• This report aims to highlight the occurrence of myocarditis due to bortezomib in a patient with multiple myeloma.
• Documented patient case with bortezomib treatment
• Monitored for symptoms of myocarditis
• Evaluated heart function and therapy response
• Early recognition of myocarditis led to drug withdrawal.
• Timely heart failure therapy facilitated full recovery.